NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 56.70

+5.1%

Nov 14 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (41)	6/22/2006 12:49:54 PM
From: Arthur Radley	Read Replies (1) of 507

Ian, I would be a little cautious..especially with the recent ruling from Europe as to what type patients will be allowed the drug under their reimbursement plans. Basically, only those with needle phobia will be allowed the drug. As this article points out, patients will basically have to get a doctor to diagnosis them with mental problems before they can use the drug...IMO, patients will be reluctant to take this step. yahoo.reuters.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next